The global vaginal slings market size is expected to reach USD 2.6 billion by 2030, according to a new report by Grand View Research, Inc, expanding at a CAGR of 4.62% from 2023 to 2030. The key factors driving the market growth include changing woman’s lifestyles and growing awareness of vaginal sling procedures or surgery. Moreover, rising demand for minimally invasive surgeries, growing female geriatric population, and increasing prevalence of stress urinary inconsistence are expected to boost the demand for the market over the forecast period.
The risk factors causing stress incontinence in women include uterine prolapse, diabetes, chronic coughing, pelvic surgery such as a hysterectomy, obesity, menopause, nerve injuries to lower back or pelvis, and pregnancy and childbirth (particularly vaginal birth). Furthermore, according to a John Wiley & Sons, Inc. research article, about 26% of women in emerging economies suffer from urinary incontinence, and the incidence of stress urinary incontinence (12.6%), is higher than that of mixed urinary incontinence (9.1%) and urgent urinary incontinence (5.3 %). Stress urinary incontinence can seriously affect a female’s quality of life leading to mental disorders, a decrease in work productivity, an increase in mortality, and social isolation. Hence, the increasing incidence of urinary incontinence is significantly increasing the demand for vaginal slings, thereby driving the market.
Moreover, urinary incontinence is a very common disorder in the geriatric population. According to a National Statistical Office report in 2021, 71 million women were aged 60 and above in 2021, and the number is expected to reach 101 million by 2031. Thus, the growing female geriatric population is anticipated to offer lucrative opportunities for the market during the study period.
Additionally, vaginal sling surgery is found to be safe, efficient, and effective, and requires minimal procedure and recovery time of about 30 to 45 minutes. Owing to its minimally invasive procedure it has replaced conventional methods such as vaginal mesh and colposuspension. Therefore, rising demand for minimally invasive surgeries is fueling the market. Furthermore, the Centers for Medicare & Medicad Services (CMS) offer reimbursements for vaginal sling procedures. Such, factors are fueling the market.
Request a free sample copy or view report summary: Vaginal Slings Market Report
Based on product, the transobturator slings segment dominated the market in 2022. The growth of the segment is attributed to the shorter operative time and a relatively lower complication rate
On the basis of type, the midurethral sling segment dominated the market with a maximum revenue share in 2022. The growth is attributed tothe advantages of the technique such as smaller incisions, minor manipulation, and minimal dissection
Based on end use, the hospitals segment dominated the market with a maximum revenue share in 2022. The growth is attributed tothe advanced facilities offered by hospitals and the requirement for longer stays in hospitals for traditional vaginal sling procedures
Europe dominated the market in 2022. The growth of the region is driven by factors such as the presence of key operating players and a large base of patient population. In addition, the increasing prevalence of chronic diseases such as diabetes and neurological diseases and the growing geriatric population are driving the market in the region
Asia Pacific is expected to witness lucrative growth from 2023 to 2030, owing to rapidly advancing healthcare facilities in countries such as Malaysia, China, India, and South Korea and growing investments by healthcare providers and operating players
Grand View Research has segmented the vaginal slings market based on product, type, end use, and region:
Vaginal Slings Product Outlook (Revenue, USD Million, 2018 - 2030)
Tension-Free Vaginal Tape Slings
Transobturator Slings
Mini-Slings
Vaginal Slings Type Outlook (Revenue, USD Million, 2018 - 2030)
Midurethral Sling
Traditional Sling
Vaginal Slings End Use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Clinics
Ambulatory Surgical Centers
Vaginal Slings Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Sweden
Norway
Denmark
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in Vaginal Slings Market
Boston Scientific Corporation
Coloplast Corp
Promedon S.A.
A.M.I. GmbH
Johnson & Johnson Services, Inc.
Betatech Medical
Caldera Medical
Neomedic International
Cousin Surgery
Lotus Surgicals
UroCure
"The quality of research they have done for us has been excellent..."